This study is a prospective cohort study to delineate the infective outcomes and incidence after transperineal prostate biopsy with no antibiotic prophylaxis, compared to the existing data on outcomes on patients receiving transperineal prostate biopsy with antibiotic prophylaxis.
Conditions: Prostate Cancer
Eligibility Criteria
Inclusion Criteria
- All consecutive patients in participating centres receiving transperineal USG-guided biopsy for any indication including:
- Elevated PSA
- Abnormal DRE
- Follow-up biopsy in active surveillance
- Suspicion of CAP recurrence after radiotherapy
- Follow-up biopsy after focal therapy
- Consenting to the study
Exclusion Criteria
- Recent suspected UTI within 1 month
- Recent culture proven bacteriuria within 1 month
- History of recurrent UTI
- Indwelling urinary catheter
- Immunocompromised state
- High risk of infective endocarditis (including prosthetic heart valve, congenital heart disease, or previous history of infective endocarditis
- Incompetent or incapable of understanding the nature of the study or giving informed consent
Eligibility criteria are kept as the original English records from ClinicalTrials.gov; actual eligibility is determined by the research team's formal assessment and the informed consent form. Source: ClinicalTrials.gov, updated automatically every two weeks. Last synced: 2026年10月8日.